CB Juhl, M Hollingdal, J Sturis, G Jakobsen, H … - Diabetes, 2002 - Am Diabetes Assoc Glucagon-like peptide 1 (GLP-1) is a potent glucose-lowering agent of potential
interest for the treatment of type 2 diabetes. To evaluate actions of NN2211, a
long-acting GLP-1 derivative, we examined 11 patients with type 2 diabetes, ... Cited by 174 - Related articles - BL Direct - All 6 versions
- ►endojournals.org CB Juhl, M Hollingdal, N Porksen, A Prange, … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc Thiazolidinediones have well-established insulin-sensitizing effects. Their
impact on insulin secretion is less clarified. Consequently, we sought to
determine potential effects of a thiazolidinedione (rosiglitazone) on the ... Cited by 53 - Related articles - BL Direct - All 4 versions
- ►jbc.org J Buteau, A Shlien, S Foisy, D Accili - Journal of Biological Chemistry, 2007 - ASBMB Diabetes is associated with decreased pancreatic -cell function and mass. It is
unclear whether diabetes treatment should aim at restoring -cell
performance/mass or at inducing " -cell rest" to prevent further ... Cited by 20 - Related articles - All 6 versions
M Hollingdal, J Sturis, MA Gall, P Damsbo, S … - Diabet Med, 2005 - interscience.wiley.com Methods We examined 10 patients with Type 2 diabetes in a double-blind
placebo-controlled, cross-over design. The participants were treated for 6 weeks
with either repaglinide [2–9 mg/day (average 5.9 mg)] or placebo in ... Cited by 11 - Related articles - BL Direct - All 6 versions
RC Earnhardt, JD Veldhuis, G Cornett, JB … - Annals of surgery, 2002 - pubmedcentral.nih.gov Pulsatile and invariant basal insulin secretion was studied in normal dogs (n =
4) and three canine models of the anatomical alterations of pancreas
transplantation: 70% partial pancreatectomy (PPX, n = 4), partial ... Cited by 5 - Related articles - BL Direct - All 4 versions
- ►physiology.org RA Ritzel, JD Veldhuis, PC Butler - American Journal of Physiology- Endocrinology And …, 2006 - Am Physiological Soc Insulin is secreted in discrete insulin secretory bursts. Regulation of insulin
release is accomplished almost exclusively by modulation of insulin pulse mass,
whereas the insulin pulse interval remains stable at 4 min. It has been ... Cited by 3 - Related articles - BL Direct - All 3 versions
N Porksen - Diabetes Research and Clinical Practice, 2006 - Elsevier Type 2 diabetes is associated with both insulin resistance and impaired insulin
secretion at diagnosis. As the disease progresses, insulin secretion is
gradually decreased. Evidently, loss of insulin secretion per se, may cause ... Cited by 2 - Related articles - All 9 versions
